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Abstract The use of aspecific methylation reaction in combina-
tion with MS procedures has been employed for the character-
ization of the nucleophilic residues present on the molecular
surface of the human 2,3-diphosphoglycerate/deoxy-hemoglobin
complex. In particular, direct molecular weight determinations
by ESMS allowed to control the reaction conditions, limiting the
number of methyl groups introduced in the modified globin
chains. A combined LCESMS-Edman degradation approach for
the analysis of the tryptic peptide mixtures yielded to the exact
identification of methylation sites together with the quantitative
estimation of their degree of modification. The reactivities
observed were directly correlated with the pKa and the relative
surface accessibility of the nucleophilic residues, calculated from
the X-ray crystallographic structure of the protein. The results
here described indicate that this methodology can be efficiently
used in aspecific modification experiments directed to the
molecular characterization of the surface topology in proteins
and protein complexes.
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1. Introduction
Chemical modi¢cation reactions on proteins have long been
employed in structure function studies aimed at identifying
active site residues, studying chemical reactivity of amino
acids, or modifying catalytic properties and proteolytic specif-
icity [1]. Di¡erent reagents have been utilized for the covalent
derivatization of a speci¢c functional group (i.e. primary
amine, imidazole ring, sulphydryl, guanidino or phenolic hy-
droxyl group) without any demonstrable e¡ect on other func-
tionalities [2]. These methodologies were greatly improved
when mass spectrometric techniques were used to determine
both the precise number and location of the derived amino
acid residues.
More recently, site-directed modi¢cations of lysine, argi-
nine, tyrosine and histidine residues have been used to probe
the surface topology of proteins or to investigate interacting
regions in protein complexes. In fact, the careful selection of
experimental conditions suitable to maintain the native con-
formation of the macromolecules and to limit the extent of
modi¢cation to mono- or di-modi¢ed species allowed to infer
information about the identity of the amino acid residues
exposed on the molecular surface of proteins [3^5]. The simul-
taneous introduction of a multiple number of modifying
groups was strongly avoided in order to limit local unfolding
of the polypeptide chain resulting in a possible perturbation of
the subtle network of interactions stabilizing the native con-
formation of the protein and in the accumulation of mislead-
ing data. Similarly, this approach was extended to localize
functional regions of the proteins exposed to the solvent
that became protected upon binding to other macromolecules
or ligands [6^8].
Most of the reagents for chemical modi¢cation described in
the literature are site speci¢c; thus, the experimental condi-
tions reported have been selected with the aim to avoid their
simultaneous reaction with amino acids presenting di¡erent
functionality. In this respect, the employment of the largest
possible number of modifying agents was encouraged in order
to obtain the largest number of information regarding the
amino acids exposed on the molecular surface of proteins.
We recently reported an analytical methodology for the
identi¢cation and quantitative evaluation of the modi¢cations
produced in hemoglobin as result of the in vitro exposition of
human red blood cells to carcinogens as methyl bromide
[9,10]. The possibility to detect even low level of methylation
(0.5^5%) for cysteine, lysine, histidine, tyrosine and aspartic
acid residues, result of the simultaneous alkylation of their
side chains, led us to investigate the possible use of this re-
agent as a probe for the study of the reactivity of the nucle-
ophile residues in proteins and protein complexes.
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2. Materials and methods
2.1. Alkylation with methyl bromide
Bubbling gaseous MeBr in cold pure ethanol prepared MeBr sol-
ution; its concentration was determined from the increase in the
weight. Ten moles of human deoxy-hemoglobin were incubated with
a 1^10-fold molar excess of MeBr in 10 ml of 10 mM sodium phos-
phate, 10 mM DPG, pH 7.5, at 37‡C, under N2 for di¡erent times.
The reactions were stopped by acidi¢cation and the mixtures were
then injected for chromatographic analysis. Due to the toxic action
of this reagent we strongly recommend special care in the experiment
settings.
2.2. Globin chains separation and LC-ESMS analysis of the tryptic
peptide mixtures
Globin chains were puri¢ed by RP-HPLC using a 214TP54 Vydac
column following the procedure previously reported [10]. Fractions
eluted were manually collected and lyophilized. Trypsin hydrolysis
was carried out in 50 mM NH4HCO3, pH 8.5, at 37‡C, overnight
using a substrate:enzyme ratio of 50:1 (w/w). Tryptic digests were
fractionated using a 218TP52 Vydac column eluted with a linear gra-
dient (5^70%) of acetonitrile in 0.03% tri£uoroacetic acid, at a £ow
rate of 200 Wl/min. The column e¥uent was split 1:25 with a tee, to
a¡ord a £ow rate of 8 Wl/min into the ES nebulizer; the remaining
e¥uent was run through an UV detector for peak collection. ES mass
spectra were recorded using a PLATFORM single quadrupole instru-
ment (Micromass, Manchester, UK) as previously reported [8,10,11].
2.3. Amino acid analysis and peptide sequencing
Ten nmoles of globins were hydrolyzed in 6 N HCl at 110‡C for
24 h, under vacuum. Quantitative GCEIMS amino acid analysis of
the protein hydrolysates was performed using a TRIO 2000 GCEIMS
apparatus (Micromass, Manchester, UK) equipped with a 5890 series
II gas chromatograph (Hewlett-Packard, Palo Alto, USA) as previ-
ously reported [12]. Peptide sequencing of intact Hb chains and pep-
tides was performed by using a Perkin Elmer-Applied Biosystems
477A protein sequencer equipped with a model 120A PTH-amino
acid analyzer as previously described [10].
2.4. Computer analysis
The structure of human deoxy-hemoglobin (Brookhaven Labora-
tory PDB ¢le 1A3N) was examined on a Silicon Graphics workstation
by using the Biosym Insight II/Discover software package. Static sol-
vent accessible areas on the protein were calculated with the program
CCP4 [13] by using a probe radius of 1.4 Aî .
3. Results and discussion
The chemical reactivity of nucleophilic residues present on
the 2,3-diphosphoglycerate/h-deoxy-Hb complex was investi-
gated by incubation of the protein in the presence of the
ligand with di¡erent molar excesses of MeBr, at neutral pH
and room temperature.
Fig. 1A shows the chromatographic pro¢le obtained using a
1:1 reagent/hemoglobin molar ratio; individual peaks were
collected and directly submitted to ESMS analysis. Measure-
ment of the accurate molecular mass of each component in-
dicated that the extent of reaction was limited only to yield
the mono-modi¢ed species. In fact, peak 1 exhibited the pres-
ence of two molecular components corresponding to the un-
modi¢ed L-globin (theoretical value 15 867.2 Da) and mono-
methylated L-globin (theoretical value 15 881.2 Da) (Fig. 1B).
Similarly, peak 2 showed the presence of two species identi¢ed
as the unmethylated K-globin (theoretical value 15 126.4 Da)
and mono-methylated K-globin (theoretical value 15 140.4 Da)
(Fig. 1C). These modi¢ed globins consisted of a population of
molecular species carrying a single modifying group but lo-
cated at di¡erent sites. In fact, GCEIMS analysis of the pu-
ri¢ed species after acid hydrolysis demonstrated that methyl-
ation occurred on N-terminal valine, cysteine and histidine
residues, respectively.
In order to identify the nature of the amino acids alkylated,
aliquots of peak 1 and 2 were individually digested with tryp-
sin and the resulting peptide mixtures analyzed by LCESMS
as previously described [10]. In most cases native and alky-
lated peptides eluted together as veri¢ed from the presence of
a satellite signal corresponding to a mass increase of 14 Da
with respect to the native peptide. The degree of methylation
for each species was calculated from the relative intensities of
their respective mass signals, assuming similar response fac-
tors in ESMS analysis [10]. The identi¢cation of the site of
methylation was obtained by direct sequencing of the intact
globins or their tryptic peptides by automated Edman degra-
dation. Moreover, the possibility to analyze simultaneously in
Fig. 1. Chromatographic separation and ESMS analysis of the glo-
bin chains generated from the reaction of the DPG/h-deoxy-Hb
complex with 1 mM MeBr. The globins were resolved as described
in Section 2 (A). Transformed ESMS spectra of the resulting L-glo-
bin species (peak 1 in panel A) (B) and K-globin species (peak 2 in
panel A) (C), respectively.
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the sequencer the methylated and unmethylated species and to
determine at each cycle the relative abundance of the PTH-
methyl amino acid with respect to the PTH-amino acid al-
lowed to have an independent measure of the degree of mod-
i¢cation for each peptide. A good correlation between the
values determined by the di¡erent approaches was obtained
as previously described [10] ; the complete identi¢cation of the
methylation sites in both globin chains and their percentage of
modi¢cation is reported in Table 1. These data demonstrated
that methylation occurred at Val-1(K), His-20(K), His-72(K),
His-89(K), His-103(K), Cys-104(K), Val-1(L), Cys-93(L), His-
97(L), Cys-112(L), His-116(L), His-117(L) and His-146(L), re-
spectively.
Similarly, this methodology allowed to characterize the re-
action products obtained by using higher reagent/hemoglobin
ratios. In all cases, protein’s solution behavior did not change,
indicating that the reaction did not a¡ect the Hb solubility. As
expected, in the case of a 10:1 molar ratio, ESMS measure-
ment of the K- and L-globin fractions indicated that the re-
action yielded a high percentage of multi-modi¢ed species; in
fact, a mixture of the penta-, esa- and epta-modi¢ed globins
was observed. Accordingly, GCEIMS analysis of the globin
hydrolysates revealed a strong increase of the percentage of
methylated amino acids. The peaks corresponding to the K-
and L-globins were pooled and analyzed as reported above,
a¡ording the identi¢cation of the methylation sites and their
percentage of modi¢cation. Thus, in addition to the residues
modi¢ed by using a 1:1 molar ratio, in this case methylation
occurred at Lys-7(K), Lys-11(K), Lys-40(K), His-45(K), His-
50(K), Lys-56(K), His-112(K), His-122(K), Lys-139(K), Lys-
17(L), His-77(L), His-92(L), His-143(L) and Lys-144(L), respec-
tively.
The results obtained with this approach demonstrated that
modi¢cation in native conditions was mainly concentrated at
speci¢c sulphydryl groups, primary amines and imidazole
rings, respectively. Only in the case of the 10:1 reagent/hemo-
globin molar ratio, a very small amount of selected NO-meth-
yl-lysine residues was also detected. On the contrary, peptide
mapping analysis of the methylated globins resulting from the
reaction of MeBr with irreversibly denatured DPG/h-deoxy-
Hb complex showed that methylation was not concentrated at
speci¢c amino acids but di¡used everywhere all over the nu-
cleophilic residues present in the polypeptide chains.
In addition, these data were consistent with the h-deoxy-Hb
structure determined by X-ray crystallography and reported
in Fig. 2, where the methylated residues obtained using a 1:1
molar ratio are reported in red. In fact, modi¢cation occurred
only at amino acid side chains exposed on the protein surface,
whereas those present into the inner core resulted inaccessible
to the reagent. Similarly, all the residues methylated using a
10:1 molar ratio were present on regions accessible to the
reagent. However, the presence of a high number of modify-
ing groups on each polypeptide chain should result in local
unfolding of the Hb tetramer, determining a possible pertur-
bation of the native conformation of the complex and in the
accumulation of misleading data. For this reason, although
these results suggested that the DPG/multi-methylated deoxy-
Hb complex still presented the native conformation, we did
not consider them for further interpretations.
The degree of methylation measured for the reactive amino
acids of the K- and L-globins by using both reagent/hemoglo-
bin molar ratios is reported in Fig. 3, together with the static
surface accessibility for the nucleophilic atoms present on N-
terminal valine, cysteine and histidine residues, calculated on
the basis of the deoxy-hemoglobin crystal structure. Quanti-
tative evaluation of the relative modi¢cation observed for the
di¡erent residues was in good agreement with the nucleophil-
icity order reported for the major groups in biological mole-
cules [14]
Rÿ S3sRÿNH2vRÿ imidazolesRÿ COO3sRÿO3
with the exception of the NO-amine of lysine side chains that
resulted poorly methylated. In addition, these results provided
evidence that the reactivity toward methylation of amino acids
having the same nature generally well correlated with their
Fig. 2. Space-¢lling representation of the human deoxy-hemoglobin
structure. K-globins are shown in blue and L-globins in green. The
amino acids modi¢ed with 1 mM MeBr are shown in red; those
methylated with 10 mM MeBr are represented in yellow. Two Hb
tetramer orientations rotated by roughly 180‡ are illustrated.
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Table 1










1 287.3 þ 0.1 (91^92) 1 317.8 þ 0.1 (145^146)
337.5 þ 0.1 (140^141) 331.8 þ 0.1 (145^146)+Me 1.4% H146 (1.7%)
460.2 þ 0.1 (8^11) 2 411.4 þ 0.1 (62^65)
2 531.9 þ 0.3 (12^16) 3 951.3 þ 0.1 (1^8)
3 728.4 þ 0.2 (1^7) 965.2 þ 0.2 (1^8)+Me 0.2% K-
NH2
n.d.
4 742.9 þ 0.3 (1^7)+Me 0.8% K-NH2 n.d. 4 1377.9 þ 0.3 (121^132)
5 1170.6 þ 0.1 (1^11) 5 1149.2 þ 0.1 (133^144)
6 1184.7 þ 0.2 (1^11)+Me 0.7% K-NH2 n.d. 1314.0 þ 0.1 (18^30)
7 1078.3 þ 0.2 (81^90) 6 1125.4 þ 0.4 (96^104)
8 817.5 þ 0.1 (93^99) 1139.6 þ 0.2 (96^104)+Me 2.8% H97 (3%)
9 1529.4 þ 0.2 (17^31) 7 1122.5 þ 0.4 (121^130)
1543.3 þ 0.1 (17^31)+Me 1.7% H20 (1.9%) 1449.8 þ 0.3 (133^146)
10 1086.6 þ 0.1 (91^99) 1463.4 þ 0.1 (133^146)+Me 1.5% H146 (1.9%)
11 1833.8 þ 0.2 (41^56) 8 1793.2 þ 0.2 (66^82)
12 1252.2 þ 0.1 (128^139) 9 931.2 þ 0.1 (9^17)
13 1071.6 þ 0.2 (32^40) 10 1148.4 þ 0.1 (133^144)
14 1936.7 þ 0.2 (62^80) 11 1420.7 þ 0.4 (83^95)
2063.2 þ 0.2 (61^80) 1434.5 þ 0.2 (83^95)+Me 3.7% C93 (4.0%)
15 3125.0 þ 0.3 (61^90) 12 1718.9 þ 0.3 (105^120)
3140.1 þ 0.1 (61^90)+Me 2.6% H72 (1.6%), 1733.7 þ 0.4 (105^120)+Me 4.8% C112 (0.6%), H116 (3.7%),
H89 (0.7%) H117 (0.9%)
16 2996.5 þ 0.3 (62^90) 13 1274.3 þ 0.3 (31^40)
3010.4 þ 0.3 (62^90)+Me 2.4% H72 (1.8%), 1669.4 þ 0.6 (67^82)
H89 (0.9%) 1797.8 þ 0.1 (66^82)
17 2967.7 þ 0.3 (100^127) 2527.2 þ 0.7 (83^104)
2982.9 þ 0.2 (100^127)+Me 1.3% H103 (0.9%), 14 2059.0 þ 0.2 (41^59)
C104 (0.4%) 15 889.2 þ 0.2 (31^37)
16 4231.7 þ 0.5 (83^120)
4245.1 þ 0.6 (83^120)+Me 12.5% C93 (3.8%), H97(3.0%),
C112 (0.7%), H116 (3.5%),
H117 (1.0%)
Fig. 3. Representation of the reactivity and the static solvent accessibility of the nucleophilic residues present in DPG/h-deoxy-Hb complex.
The percentage of methylation obtained with 1 mM MeBr and 10 mM MeBr (determined by Edman degradation and ESMS analysis) are
shown in black and gray, respectively. The static solvent accessible areas on the protein were calculated with the program CCP4 [12] using a
probe radius of 1.4 Aî and are shown in white.
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relative static surface accessibility. As an example, the per-
centage of PTH-methyl-Cys recovered for cysteine residues
using a 1:1 molar ratio was higher for Cys-93(L), than Cys-
112(L) and Cys-104(K) and proportional to the exposition of
their sulphur atoms on the protein surface.
A signi¢cant deviation was found only in the case of some
histidine residues; in particular, His-45(K), His-50(K), His-
112(K), His-2(L), His-77(L) and His-143(L) were not modi¢ed
by using the 1:1 reagent/hemoglobin molar ratio with respect
to their high accessibility on protein surface. The low reactiv-
ity of His-2(L) and His-143(L) was expected on the basis of the
masking e¡ect due to the 2,3-diphosphoglycerate. In fact, it
has been previously reported that these amino acids are essen-
tial in binding to this ligand [15]. Quantitative experiments on
deoxy-hemoglobin in the absence of DPG showed a methyl-
ation pattern almost identical to that reported in Fig. 3 and to
the results previously published in the case of the in vitro
exposed human red blood cells [10]. An increased reactivity
was observed only for His-2(L) and His-143(L), whose per-
centage of methylation resulted 2.1 and 1.5, respectively.
These results were in perfect agreement with the reported
masking e¡ect exerted from the ligand and with the crystallo-
graphic data indicating that binding of DPG results in poor
changes in the tertiary structure of the K- and L-subunits [15].
Similarly, the poor methylation observed for His-45(K),
His-50(K), His-112(K) and His-77(L) was easily explained in
terms of changes in their pKa due to microenvironmental
e¡ects experienced by an acid functionality close to these res-
idues within the three-dimensional structure of the complex.
In fact, a careful analysis of the structure of the deoxy-hemo-
globin tetramer around these amino acids revealed that the
NO2 of His-45(K) is in close proximity (3.5 Aî ) to the carbox-
ylate of the heme; similarly, the NN1 of His-50(K) is able to
give an ionic interaction with Glu-30(K). The side chain of
Asp-73(L) introduces a negative charge within a few ang-
stroms of His-77(L), whilst His-112(K) presents a double hy-
drogen bond with the carboxylate of Glu-27(K) (NN1) and the
phenolic hydroxylate of Tyr-24(K) (NO2), respectively. These
interactions would be expected to produce an electrostatic
stabilization of the protonated form of the imidazole rings,
with a consequent reduced nucleophilicity of these histidine
residues [16].
The results obtained on human deoxy-hemoglobin clearly
demonstrate that aspeci¢c chemical modi¢cation experiments
can be designed to probe simultaneously the accessibility of
amino acids having di¡erent nature on the surface of proteins
and to gain information on protein tertiary and quaternary
structure. In fact, our experiments demonstrated that all the
residues labeled by MeBr were found exposed on the molec-
ular surface. However, in these studies local factors a¡ecting
the normal pKa of the reacting side chains and, hence, their
nucleophilicity values according to the Bro«nsted relationship,
have to be carefully considered. In fact, as described above,
amino acids not modi¢ed by MeBr can be anyhow present on
the molecular surface of the system under investigation. Fur-
thermore, this methodology was usefully extended to localize
functional regions of the macromolecule protected upon bind-
ing to ligands as DPG, showing its applicability to the study
of protein complexes.
We would like to emphasize again in these studies the im-
portance of the experimental conditions, which have to be
selected in order to ensure the maintenance of the protein
native conformation or the stability of the complex. There-
fore, in the case of proteins whose three-dimensional struc-
tures have not yet been determined, the use of reagent con-
centrations able to a¡ord only the mono- or di-modi¢ed
products is strongly recommended in order to obtain data
on the surface topology of the system under investigation,
avoiding the acquisition of erroneous information. On the
contrary, additional experiments using high protein/reagent
molar ratios could be suggested for the study of the reactivity
of amino acids in proteins whose structures have yet been
elucidated. In this respect, a reagent as MeBr, able to intro-
duce a modifying group with low steric hindrance, could be
considered as a choice of excellence. In these cases, the e¡ect
of the simultaneous presence of an increased number of meth-
yl groups on protein conformation has to be carefully eval-
uated.
Therefore, this approach can be considered as an additional
tool to the selective chemical modi¢cation and limited pro-
teolysis methodologies previously reported for studies directed
to the identi¢cation of residues exposed on the molecular sur-
face [5,8,11,17^19]. Thus, the use of these mass spectrometric
procedures will provide preliminary or complementary data
on protein and protein complexes to be completed with
more traditional techniques as circular dichroism, X-ray crys-
tallography, nuclear magnetic resonance and £uorescence
spectroscopies.
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